[1]陈 甜,付朝霞.中性粒细胞明胶酶相关脂质运载蛋白对早期糖尿病肾病的诊断价值[J].医学信息,2023,36(23):95-98.[doi:10.3969/j.issn.1006-1959.2023.23.024]
 CHEN Tian,FU Zhao-xia.Diagnostic Value of Neutrophil Gelatinase-associated Lipocalin in Early-stage Diabetic Nephropathy[J].Journal of Medical Information,2023,36(23):95-98.[doi:10.3969/j.issn.1006-1959.2023.23.024]
点击复制

中性粒细胞明胶酶相关脂质运载蛋白对早期糖尿病肾病的诊断价值()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年23期
页码:
95-98
栏目:
论著
出版日期:
2023-12-01

文章信息/Info

Title:
Diagnostic Value of Neutrophil Gelatinase-associated Lipocalin in Early-stage Diabetic Nephropathy
文章编号:
1006-1959(2023)23-0095-04
作者:
陈 甜付朝霞
(高安市人民医院检验科,江西 高安 330800)
Author(s):
CHEN TianFU Zhao-xia
(Laboratory of Gao’an People’s Hospital,Gao’an 330800,Jiangxi,China)
关键词:
早期糖尿病肾病中性粒细胞明胶酶相关脂质运载蛋白肾小球滤过率尿白蛋白/肌酐比值肾损伤
Keywords:
Earlystage diabetes nephropathyNeutrophil gelatinase associated lipid transporter proteinGlomerular filtration rateUrinary albumin/creatinine ratioRenal injury
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2023.23.024
文献标志码:
A
摘要:
目的 研究中性粒细胞明胶酶相关脂质运载蛋白(NGAL)对早期糖尿病肾病(DN)的诊断价值。方法 将2020年1月-2023年1月高安市人民医院收治的82例早期DN患者设为DN组,另取同期就诊的50例单纯糖尿病患者设为DM组,检测两组患者的NGAL水平、尿白蛋白/肌酐比值(UACR)、肾小球滤过率(eGFR)指标,分析NGAL指标对早期DN的诊断价值,另比较不同肾损伤分级患者的NGAL、UACR、eGFR水平,采用Spearman相关性分析NGAL水平与UACR、eGFR的关系。结果 DN组NGAL、UACR水平高于DM组,eGFR水平低于DM组(P<0.05)。经ROC曲线分析显示,NGAL检测对早期DN疾病具有确切诊断价值,其AUC值为0.836,敏感性为90.14%,特异性为87.62%,约登指数为0.875,95%CI区间为0.682~0.914。不同肾损伤分级患者的NGAL、UACR、eGFR水平比较,差异有统计学意义(P<0.05),其中NGAL、UACR指标由高至低依次为Ⅲ期>Ⅱ期>Ⅰ期,eGFR指标由高至低依次为Ⅰ期>Ⅱ期>Ⅲ期。Spearman相关性分析显示,DN患者的NGAL水平与UACR呈正相关(r=0.502,P=0.000),与eGFR呈负相关(r=-0.473,P=0.000)。结论 NGAL指标对早期DN疾病具有良好诊断价值,其参数水平与患者肾损伤程度密切相关。
Abstract:
Objective To study the diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) in early-stage diabetic nephropathy (DN).Methods A total of 82 patients with early-stage DN admitted to Gao’an People’s Hospital from January 2020 to January 2023 were set as DN group, and 50 patients with simple diabetes were set as DM group. The NGAL level, urinary albumin/creatinine ratio (UACR) and glomerular filtration rate (eGFR) of the two groups were detected, and the diagnostic value of NGAL index for early DN was analyzed. The levels of NGAL, UACR and eGFR in patients with different renal injury grades were compared. Spearman correlation was used to analyze the relationship between NGAL level and UACR and eGFR.Results The levels of NGAL and UACR in DN group were higher than those in DM group, and the level of eGFR was lower than that in DM group (P<0.05). ROC curve analysis showed that NGAL detection had a definite diagnostic value for early DN disease. The AUC value was 0.836, the sensitivity was 90.14%, the specificity was 87.62%, the Youden index was 0.875, and the 95%CI interval was 0.682-0.914. The levels of NGAL, UACR and eGFR in patients with different renal injury grades were statistically significant (P<0.05). The NGAL and UACR indexes from high to low were stage Ⅲ> stage Ⅱ> stage Ⅰ, and the eGFR indexes from high to low were stage Ⅰ> stage Ⅱ> stage Ⅲ. Spearman correlation analysis showed that NGAL level in DN patients was positively correlated with UACR (r=0.502, P=0.000) and negatively correlated with eGFR (r=-0.473, P=0.000).Conclusion NGAL index has good diagnostic value for early DN disease, and its parameter level is closely related to the degree of renal injury in patients.

参考文献/References:

[1]陈筱涛,刘韵,龙碧莹,等.血清总胆红素联合中性粒细胞明胶酶相关脂质运载蛋白对2型糖尿病肾病患者病情发展的预测价值[J].中国医药,2022,17(6):859-862.[2]何英姿,张亚芳,符爱贞,等.妊娠期糖尿病患者血清中性粒细胞明胶酶相关脂质运载蛋白表达及与病情关系[J].中国计划生育学杂志,2022,30(5):1115-1118.[3]冯小娟,薄维波,韦丽丽,等.血清DKK1、NGAL和MCP-1在2型糖尿病肾病患者中的表达及临床意义[J].检验医学与临床,2022,19(9):1243-1247.[4]胡广梅,蒋金良,丁睿.急性肾损伤患者中性粒细胞明胶酶相关脂质运载蛋白动态变化及意义[J].中国卫生检验杂志,2022,32(6):735-737,746.[5]屈晓威,赵冬,冯莉莉,等.尿ZAG、KIM-1和NGAL联合检测在糖尿病肾病诊断中的临床价值[J].临床和实验医学杂志,2021,20(23):2558-2561.[6]张佳思,邹春波,卢宇,等.血脂蛋白磷脂酶A2和中性粒细胞明胶酶相关脂质运载蛋白在诊断早期糖尿病肾病中的价值[J].上海交通大学学报(医学版),2021,41(6):770-775.[7]樊玲英,俸家富.血清C1q和NGAL及CysC联合检测对早期糖尿病肾病辅助诊断的临床评价[J].中华检验医学杂志,2018,41(11):847-852.[8]中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志,2021,37(3):255-304.[9]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华内分泌代谢杂志,2021,37(4):311-398.[10]喻敏,刘春雅,姜毅,等.联合血清中性粒细胞明胶酶相关脂质运载蛋白、转铁蛋白以及超敏C-反应蛋白检测诊断糖尿病肾病的价值探讨[J].中国卫生检验杂志,2020,30(23):2890-2893.[11]雷智莉.99mTc-二乙烯三胺五乙酸肾动态显像联合血清中性粒细胞明胶酶相关脂质运载蛋白胱抑素C检测在糖尿病肾病早期诊断中的应用[J].中国药物与临床,2020,20(20):3466-3467.[12]陈莹.血、尿NGAL在2型糖尿病肾病进展各阶段的变化及其临床意义[J].心血管康复医学杂志,2020,29(1):90-93.[13]刘运双,张彬,张亚梅,等.血清NGAL对早期诊断2型糖尿病肾病的临床价值[J].热带医学杂志,2020,20(1):97-101.[14]朱勤惠,李祥,卢玉振,等.血清中性粒细胞明胶酶相关脂质运载蛋白、尾加压素Ⅱ和胱抑素C联合检测对早期糖尿病肾病的诊断价值[J].江苏大学学报(医学版),2019,29(6):535-537,541.[15]Bulluck H,Maiti R,Chakraborty B,et al.Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality[J].Heart,2018,104(4):313-317.[16]李秀珍,谭晓,高逸冰,等.血清中性粒细胞明胶酶相关脂质运载蛋白对对比剂肾病的早期预测价值[J].中华老年多器官疾病杂志,2019,18(3):210-213.[17]康福新,王小智,刘润,等.中性粒细胞明胶酶相关脂质运载蛋白变化值对成人ICU患者发生急性肾损伤的诊断价值[J].实用医学杂志,2019,35(5):760-763.[18]邓琳,丁怡,汪萍,等.尿中性粒细胞明胶酶相关脂质运载蛋白/肌酐比值在2型糖尿病肾损伤的早期诊断及病情评估中的临床应用[J].诊断学理论与实践,2019,18(1):61-65.[19]储辉,林宁,刘艳秋,等.尿ZAG、KIM-1和NGAL联合检测在糖尿病肾病诊断中的价值[J].国际检验医学杂志,2021,42(1):83-86,90.[20]赵亚妮,王君,赵棉.血清β2微球蛋白、视黄醇结合蛋白、胱抑素C、中性粒细胞明胶酶相关脂质运载蛋白及基质金属蛋白酶2多指标联合检测在糖尿病肾病患者中的价值[J].实用临床医药杂志,2018,22(13):20-23.[21]张会芬,杨宏秀,刘丽,等.血清中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C及尿白蛋白肌酐比值、N-乙酰-β-D-氨基葡萄糖苷酶检测在早期糖尿病肾脏疾病中的应用价值[J].中国糖尿病杂志,2018,26(4):309-315.[22]杨渝伟,陈小红,胡冬,等.血清中性粒细胞明胶酶相关脂质运载蛋白水平与卒中发生及患者肾功能损害的关系[J].现代检验医学杂志,2018,33(2):23-27.

相似文献/References:

[1]陈超逸,赵弯弯,黄 婷,等.NGAL与急性肾损伤患者的临床相关性分析[J].医学信息,2021,34(15):50.[doi:10.3969/j.issn.1006-1959.2021.15.014]
 CHEN Chao-yi,ZHAO Wan-wan,HUANG Ting,et al.Analysis of Clinical Correlation Between NGAL and Acute Kidney Injury[J].Journal of Medical Information,2021,34(23):50.[doi:10.3969/j.issn.1006-1959.2021.15.014]
[2]张 巍,吴 颖,肖 烽,等.脓毒症并发急性肾损伤患者血浆铁水平与NGAL的相关性研究[J].医学信息,2022,35(06):1.[doi:10.3969/j.issn.1006-1959.2022.06.001]
 ZHANG Wei,WU Ying,XIAO Feng,et al.Correlation Between Plasma Iron Level and NGAL in Sepsis Patients with Acute Kidney Injury[J].Journal of Medical Information,2022,35(23):1.[doi:10.3969/j.issn.1006-1959.2022.06.001]

更新日期/Last Update: 1900-01-01